Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Current Taxes: 2011-2024

Historic Current Taxes for Anika Therapeutics (ANIK) over the last 8 years, with Dec 2024 value amounting to $63,000.

  • Anika Therapeutics' Current Taxes fell 95.64% to $65,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $65,000, marking a year-over-year decrease of 95.64%. This contributed to the annual value of $63,000 for FY2024, which is 94.92% down from last year.
  • Per Anika Therapeutics' latest filing, its Current Taxes stood at $63,000 for FY2024, which was down 94.92% from $1.2 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Current Taxes registered a high of $1.2 million during FY2023, and its lowest value of $63,000 during FY2024.
  • For the 3-year period, Anika Therapeutics' Current Taxes averaged around $704,333, with its median value being $810,000 (2022).
  • Per our database at Business Quant, Anika Therapeutics' Current Taxes spiked by 53.09% in 2023 and then plummeted by 94.92% in 2024.
  • Anika Therapeutics' Current Taxes (Yearly) stood at $810,000 in 2022, then spiked by 53.09% to $1.2 million in 2023, then plummeted by 94.92% to $63,000 in 2024.